Sorafenib as adjuvant therapy following radiofrequency ablation for recurrent hepatocellular carcinoma within Milan criteria: a multicenter analysis.
Journal Information
Full Title: J Gastroenterol
Abbreviation: J Gastroenterol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Gastroenterology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Conflict of interestThe authors declare no conflicts of interest. Ethics statementThe Ethics Committee Board of the four hospitals approved this retrospective study and waived the requirement for patient consent for this retrospective review. Conflict of interest The authors declare no conflicts of interest."
"Funding This research was funded by the National Natural Science Foundation of China (No. 81627803, 91859201)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025